Testing Women with Invasive Lobular Breast Cancer for BRCA Mutations.

被引：0
|
作者：
Turco, D. L. [1 ]
Elsayegh, N. [1 ]
Litton, J. [1 ]
Hortobagyi, G. N. [1 ]
Arun, B. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P2-13-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-13-04
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Adverse changes in body composition of cancer surivors with BRCA mutations.
    Caceres, Aileen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?
    Passaperuma, K.
    Warner, E.
    Hill, K. A.
    Gunasekara, A.
    Yaffe, M. J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 313 - 313
  • [33] Is Mammographic Breast Density a Breast Cancer Risk Factor in Women With BRCA Mutations?
    Passaperuma, Kavitha
    Warner, Ellen
    Hill, Kimberley A.
    Gunasekara, Anoma
    Yaffe, Martin J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (23) : 3779 - 3783
  • [34] Superior pathological complete response to neo-adjuvant chemotherapy in breast cancer amongst women with BRCA1/2 mutations.
    Paluch-Shimon, S.
    Papa, M. Z.
    Friedman, E.
    Shabtai, M.
    Yosepovich, A.
    Modiano, T.
    Goldfarb, A.
    Catane, R.
    Kaufman, B.
    CANCER RESEARCH, 2009, 69 (02) : 331S - 331S
  • [35] Genetic testing for BRCA mutations in breast cancer in Europe: Barriers and opportunities
    Ahmed, S.
    Wait, S.
    Thrift-Perry, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S146 - S146
  • [36] Immunophenotypic characterization of breast cancers in carriers of BRCA1/BRCA2 mutations.
    Simon, SD
    Bacchi, CE
    Molina, AL
    Moreira-Filho, CA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 870S - 870S
  • [37] Preventing Future Cancers by Testing Women With Ovarian Cancer for BRCA Mutations
    Kwon, Janice S.
    Daniels, Molly S.
    Sun, Charlotte C.
    Lu, Karen H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) : 675 - 682
  • [38] Incorporation of genetic testing into primary treatment of invasive breast cancer (BrCa)
    Graham, ML
    Evans, JP
    Booker, JK
    Skrzynia, C
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S77 - S77
  • [39] Immunohistochemical profile of hereditary breast cancer not attributable to BRCA1 and BRCA2 mutations. A tissue microarray study
    Palacios, J
    Honrado, E
    Rivas, C
    Lerma, E
    Sanchez, L
    Diez, O
    Alonso, MC
    Prat, J
    Benitez, J
    LABORATORY INVESTIGATION, 2003, 83 (01) : 42A - 42A
  • [40] Immunohistochemical profile of hereditary breast cancer not attributable to BRCA1 and BRCA2 mutations. A tissue microarray study
    Palacios, J
    Honrado, E
    Rivas, C
    Lerma, E
    Sanchez, L
    Diez, O
    Alonso, MC
    Prat, J
    Benitez, JW
    MODERN PATHOLOGY, 2003, 16 (01) : 42A - 42A
12345